Ravin Garg is a Hematologist Oncology specialist and an Oncologist in Baltimore, Maryland. Dr. Garg is rated as a Distinguished provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Paget Disease of the Breast, Breast Cancer, and Thrombotic Thrombocytopenic Purpura.

Dr. Robert Brodsky is a professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is classical hematology and haploidentical bone marrow transplant for sickle cell disease and aplastic anemia. Dr. Brodsky serves as the director of the Division of Hematology and the T32 Training Program. He is the Johns Hopkins Family Professor of Medicine and Oncology. He received his M.D. from Hahnemann University. He completed his residency at the Vanderbilt University School of Medicine. He performed a fellowship in hematology at the National Institutes of Health and a fellowship in oncology at Johns Hopkins. He joined the Johns Hopkins faculty in 1997. From 2017 to 2022 he served as Associate Editor to The Journal of Clinical Investigation (JCI) and Secretary to American Society of Hematology (ASH). He serves as President of The American Society of Hematology (ASH) in 2023. Dr. Brodsky is rated as an Advanced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, Anemia, Bone Marrow Transplant, and Splenectomy.

Dr. C. John Sperati is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include renal medicine. Dr. Sperati is Director of the Glomerular Diseases Fellowship Program since 2023 and formerly directed the Nephrology Fellowship Training Program from 2019 - 2025. He was the long-serving Firm Faculty Leader of the Barker Firm and has held leadership positions within the Osler Medical Residency training program. In addition, he co-directs the Johns Hopkins Osler Learning Initiative which brings the principles of medical residency training to executive education worldwide. He obtained his medical degree from The Pennsylvania State University College of Medicine and a Master in Health Science from the Johns Hopkins Bloomberg School of Public Health. He completed an internship and residency in Internal Medicine at the Johns Hopkins Hospital, followed by a year as an Assistant Chief of Service (chief resident). He subsequently pursued subspecialty training in nephrology at the Johns Hopkins Hospital and joined the faculty in the Division of Nephrology. Dr. Sperati’s clinical interests are in thrombotic microangiopathy including atypical hemolytic uremic syndrome (aHUS), complement-mediated kidney diseases including C3 glomerulopathy, glomerular disease such as glomerulonephritis (e.g., IgA nephropathy, MPGN) and nephrotic syndromes (e.g., FSGS, membranous, minimal change, amyloidosis, and others), and secondary and resistant hypertension (e.g., fibromuscular dysplasia, atherosclerotic renal arterial disease, hyperaldosteronism, and genetic hypertensive syndromes). He is the site principal investigator for clinical trials in glomerular disease, serves on editorial boards, and chairs the approval committee of the Longitudinal Knowledge Assessment for nephrology for the American Board of Internal Medicine. His clinical acumen and educational contributions have been recognized by induction into the Miller Coulson Academy of Clinical Excellence as well as the American Society of Nephrology Distinguished Educator Award in 2020. He has been recognized as a physician resource through the Atypical HUS Foundation, a NephCure glomerular disease specialist, an IgA Nephropathy Foundation specialist, and a Baltimore TopDoc. He is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Sperati is rated as an Advanced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are Atypical Hemolytic Uremic Syndrome (aHUS), D-Plus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, Glomerulonephritis, and Kidney Transplant.

Stuart Selonick is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Selonick is rated as a Distinguished provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Idiopathic Neutropenia, and Lung Cancer. Dr. Selonick is currently accepting new patients.

Jeanine Werner is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Werner is rated as a Distinguished provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Virilizing Ovarian Tumor. Dr. Werner is currently accepting new patients.

Christopher Ish, M.D., practices internal medicine and pediatrics at Johns Hopkins Community Physicians Glen Burnie. He also serves as office medical director at the practice. Dr. Ish received his medical degree from the University of Medicine and Dentistry of New Jersey and completed his residency training in internal medicine and pediatrics at University of Maryland Medical Center in Baltimore. He is an instructor of medicine at The Johns Hopkins University School of Medicine in Baltimore. Dr. Ish is rated as an Experienced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Sitosterolemia, and Scleroderma.

Dr. Tanguy Seiwert is an oncologist in Baltimore, caring for patients with head and neck cancer. He serves as the director of the Head and Neck Cancer Oncology Disease Program and the co-director of the Bloomberg~Kimmel Institute for Immunotherapy at the Head and Neck Cancer Program at the Johns Hopkins School of Medicine. Dr. Seiwert earned his M.D. at Johannes Gutenberg Universität in Mainz, Germany. He completed his residency at the Duke University School of Medicine and performed a fellowship in hematology/oncology at the University of Chicago Medicine Mitchell Hospital-Hyde Park. Dr. Seiwert joined the Johns Hopkins faculty in 2019. Prior to joining Johns Hopkins, Dr. Seiwert was director of the Head and Neck Cancer Program at the University of Chicago. Dr. Seiwert’s research interests include immunologic and genomic profiling. He has given numerous invited talks on head and neck cancer both nationally and internationally. Dr. Seiwert served as chief editor for Frontiers in Head and Neck Cancer and as an editorial board member for the Journal of Clinical Oncology and Oral Oncology. He is a reviewer for multiple medical journals, including Lancet Oncology, Annals of Oncology and Clinical Cancer Research. He has been recognized by the American Association for Clinical Oncology for multiple Merit Awards and a Young Investigator Award. He was a member of the NCI Head and Neck Cancer Steering Committee, and is a member of the American Association for Clinical Oncology, the Society for Immunotherapy of Cancer, and the European Society of Clinical Oncology. Dr. Seiwert is rated as an Experienced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are Glioma, Laryngeal Cancer, Tongue Cancer, Oral Squamous Cell Carcinoma, and Gastrostomy.

Mohamed G. Atta, MD, MPH, is Professor of Medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland and Director of Von Hippel Lindau Clinical Care Center at Hopkins. A graduate of Mansoura University School of Medicine in Egypt, he completed his internship and residency training in various locations including the Urology and Nephrology Center at Mansoura University, Cabrini Medical Center in New York, and Johns Hopkins University School of Medicine. Dr. Atta received his MPH degree from Johns Hopkins Bloomberg School of Public Health in 2005. Dr. Atta is a member of the Health Disparity Committee at the Department of Health and Mental Hygiene in Maryland, the Scientific Council on Kidney of the American Heart Association, the International Society of Nephrology, and the American Society of Nephrology. Dr. Atta has participated as principal investigator in several studies, clinical trials, and serves as a peer reviewer for the Journal of Clinical Investigation, Archives of Internal Medicine, American Journal of Medicine, Kidney International, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Clinical Infectious Disease, and Journal of Infectious Diseases among others. He authored or co-authored numerous articles published in Genomics, the Journal of Biological Chemistry, Journal of clinical investigation, Clinical Infectious Disease, Circulation, Stem Cells Translational Medicine, American Journal of Medicine, and American Journal of Transplantation, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Disease, Nephrology Dialysis Transplantation, and Kidney International, among others. Dr. Atta is rated as an Experienced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are End-Stage Renal Disease (ESRD), Glomerulonephritis, Lupus Nephritis, Chronic Kidney Disease, and Kidney Transplant.

Ann Zimrin is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Zimrin is rated as an Advanced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. Her top areas of expertise are Thrombocytopenia, Sickle Cell Disease, Hemoglobinopathy, Hemoglobin C Disease, and Splenectomy. Dr. Zimrin is currently accepting new patients.

Michael Streiff is a Hematologist in Baltimore, Maryland. Dr. Streiff is rated as an Advanced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are Venous Thromboembolism (VTE), Deep Vein Thrombosis, Pulmonary Embolism, Pancreaticoduodenectomy, and Bone Marrow Aspiration.

Stanley Watkins is an Oncologist and a Hematologist in Annapolis, Maryland. Dr. Watkins is rated as an Advanced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Thrombotic Thrombocytopenic Purpura, Non-Hodgkin Lymphoma, and Pancreaticoduodenectomy.

Alison Moliterno is a Hematologist in Baltimore, Maryland. Dr. Moliterno is rated as an Advanced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. Her top areas of expertise are Myeloproliferative Neoplasms (MPN), Polycythemia Vera, Essential Thrombocythemia, Myelofibrosis, and Bone Marrow Aspiration. Dr. Moliterno is currently accepting new patients.

Ellegant Pearson is a primary care provider, practicing in Internal Medicine in Glen Burnie, Maryland. Dr. Pearson is rated as an Advanced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. Her top areas of expertise are Thrombotic Thrombocytopenic Purpura, Type 2 Diabetes (T2D), Glucocorticoid-Remediable Aldosteronism, and Familial Hypertension. Dr. Pearson is currently accepting new patients.

Jun Sun is a Hematologist Oncology specialist and a Hematologist in Brandywine, Maryland. Dr. Sun is rated as an Advanced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Anemia, and Pulmonary Embolism. Dr. Sun is currently accepting new patients.

Adam Goldrich is a Hematologist Oncology specialist and a Hematologist in Laurel, Maryland. Dr. Goldrich is rated as an Experienced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Multiple Myeloma. Dr. Goldrich is currently accepting new patients.

Qamar Zaman is a Hematologist Oncology provider in Cumberland, Maryland. Dr. Zaman is rated as an Experienced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are Anal Cancer, Thrombocytopenia, Non-Hodgkin Lymphoma, Gastric Lymphoma, and Bone Marrow Aspiration. Dr. Zaman is currently accepting new patients.

Michael Basuel is a Nephrologist in Cambridge, Maryland. Dr. Basuel is rated as an Experienced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Acute Kidney Failure, and Low Sodium Level. Dr. Basuel is currently accepting new patients.

Evan Braunstein is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Braunstein is rated as an Experienced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are Myeloproliferative Neoplasms (MPN), Essential Thrombocythemia, Myelofibrosis, Sickle Cell Disease, and Bone Marrow Aspiration. Dr. Braunstein is currently accepting new patients.

Anish Nanavati is a Hematologist Oncology provider in Waldorf, Maryland. Dr. Nanavati has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Breast Cancer, and Anemia. Dr. Nanavati is currently accepting new patients.

Elwood Holland is a primary care provider, practicing in Family Medicine in Ellicott City, Maryland. Dr. Holland is rated as an Experienced provider by MediFind in the treatment of Thrombotic Thrombocytopenic Purpura. His top areas of expertise are Thrombotic Thrombocytopenic Purpura, Type 2 Diabetes (T2D), Adult Immune Thrombocytopenia, and Immune Thrombocytopenic Purpura (ITP).